Who owns PACIRA BIOSCIENCES INC?
- CUSIP Number: 695127aj9
Tip: Access positions for across all investors
Analyze quarterly positions in Pacira Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pacira Biosciences stock
Who bought or sold PACIRA BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 109M | $110M | 2% | Dec 2025 |
|
| Context Capital Management | 81M | $79M | 18% | Mar 2026 |
|
| Lazard Asset Management | 13M | $130k | -25% | Mar 2026 |
|
| Absolute Investment Advisers | 9.0M | $8.7M | 0% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 8.0M | $7.7M | 0% | Mar 2026 |
|
| Wellesley Investment Advisors | 7.2M | $7.0B | 114% | Mar 2026 |
|
| Leucadia National Corporation | 7.0M | $6.8M | -2% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 6.6M | $6.4M | -47% | Mar 2026 |
|
| Calamos Advisors | 6.5M | $6.3M | 0% | Mar 2026 |
|
| Capstone Investment Advisors | 5.0M | $4.8M | 0% | Mar 2026 |
|
| BlackRock | 4.4M | $4.3M | 21% | Mar 2026 |
|
| SSI Investment Management | 4.0M | $3.9M | 100% | Mar 2026 |
|
| FMR | 3.4M | $3.5M | 0% | Dec 2025 |
|
| Advent Capital Management | 3.3M | $3.2M | 0% | Mar 2026 |
|
| Citigroup | 1.8M | $1.7M | 100% | Mar 2026 |
|
| Cutler Capital Management | 1.5M | $1.4M | -1% | Mar 2026 |
|
| Jane Street | 275k | $264k | 100% | Mar 2026 |
|
| Ares Systematic Credit | 100k | $97k | -50% | Mar 2026 |
|
| CSS | 75k | $73k | 0% | Mar 2026 |
|
| Virtus ETF Advisers | 44k | $42k | 0% | Mar 2026 |
|
| Cetera Investment Advisers | 24k | $23k | 100% | Mar 2026 |
|
| Insigneo Advisory Services | 10k | $9.6k | -17% | Mar 2026 |
|
Who sold out of Pacira Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Silverback Asset Management | Dec 2025 | 12M | $12M |
| Jpmorgan Chase & Co | Sep 2025 | 1.9M | $1.9M |
| Gabelli Funds | Sep 2025 | 1.3M | $1.3M |